FI894566A - Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents

Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar. Download PDF

Info

Publication number
FI894566A
FI894566A FI894566A FI894566A FI894566A FI 894566 A FI894566 A FI 894566A FI 894566 A FI894566 A FI 894566A FI 894566 A FI894566 A FI 894566A FI 894566 A FI894566 A FI 894566A
Authority
FI
Finland
Prior art keywords
pharmaceutiska
benzazepiner
blandningar
substituerade
alkyl
Prior art date
Application number
FI894566A
Other languages
English (en)
Finnish (fi)
Other versions
FI894566A0 (fi
Inventor
Joel G Berger
Wei K Chang
Marjorie Peters
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI894566A publication Critical patent/FI894566A/fi
Publication of FI894566A0 publication Critical patent/FI894566A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI894566A 1987-03-27 1989-09-27 Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar. FI894566A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3213587A 1987-03-27 1987-03-27
PCT/US1988/000899 WO1988007526A1 (en) 1987-03-27 1988-03-24 Substituted benzazepines, their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
FI894566A true FI894566A (fi) 1989-09-27
FI894566A0 FI894566A0 (fi) 1989-09-27

Family

ID=21863286

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894566A FI894566A0 (fi) 1987-03-27 1989-09-27 Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar.

Country Status (18)

Country Link
EP (2) EP0357641A1 (da)
JP (1) JPH0662574B2 (da)
KR (1) KR930011489B1 (da)
AT (1) ATE112766T1 (da)
AU (1) AU619744B2 (da)
CA (1) CA1321195C (da)
DE (1) DE3851769T2 (da)
DK (1) DK165688C (da)
FI (1) FI894566A0 (da)
HU (1) HU205744B (da)
IL (1) IL85855A (da)
MY (1) MY103357A (da)
NO (1) NO174507B (da)
NZ (1) NZ224038A (da)
PH (1) PH27337A (da)
PT (1) PT87068B (da)
WO (1) WO1988007526A1 (da)
ZA (1) ZA882080B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK107688D0 (da) * 1988-03-01 1988-03-01 Novo Industri As Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
AU8201591A (en) * 1990-06-15 1992-01-07 Schering Corporation 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substitued benzazepines and pharmaceutical compositions containing them
WO1992005157A1 (en) * 1990-09-25 1992-04-02 Schering Corporation Peri-condensed benzazepines
US5241065A (en) * 1992-02-25 1993-08-31 Schering Corporation 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
ATE305454T1 (de) * 2000-07-05 2005-10-15 Ortho Mcneil Pharm Inc Nichtpeptidische substituierte spirobenzoazepine als vasopressin antagonisten
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
CA2509413C (en) * 2002-12-20 2012-05-01 Glaxo Group Limited Benzazepine derivatives for the treatment of neurological disorders
EP1646623A2 (en) 2003-05-22 2006-04-19 Schering Corporation 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
ES2571220T3 (es) 2003-06-17 2016-05-24 Arena Pharm Inc Clorhidrato de 8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepina
WO2005003096A1 (en) 2003-06-17 2005-01-13 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
AU2012200805B2 (en) * 2003-06-17 2015-01-22 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
US20070275949A1 (en) * 2003-10-22 2007-11-29 Arena Pharmaceuticals, Inc. Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases
US20080009478A1 (en) * 2003-10-22 2008-01-10 Arena Pharmaceuticals, Inc. Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
US8168624B2 (en) 2004-12-21 2012-05-01 Arena Pharmaceuticals, Inc. Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
CN102627607A (zh) 2004-12-23 2012-08-08 艾尼纳制药公司 5HT2c受体调节剂组合物和使用方法
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
SG177128A1 (en) 2006-12-05 2012-01-30 Arena Pharm Inc Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2012030957A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
MX2013002418A (es) 2010-09-01 2013-08-01 Arena Pharm Inc Administracion de lorcaserina a individuos con daño renal.
CN103189053A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 用于体重控制的5-ht2c激动剂的调节释放剂型
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
MY181736A (en) 2012-10-09 2021-01-05 Arena Pharm Inc Method of weight management
HU230826B1 (hu) 2014-11-19 2018-07-30 Richter Gedeon Nyrt. Eljárás benzazepin származékok előállítására

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
DE1934150A1 (de) * 1968-07-10 1970-01-15 Pennwalt Corp Neue 1-Alkanoyloxy-1,2,4,5-tetrahydro-3H,3-benzazepine
US4988690A (en) * 1982-06-14 1991-01-29 Hoechst-Roussel Pharmaceuticals Inc. 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
US4707483A (en) * 1985-12-20 1987-11-17 Smithkline Beckman Corporation 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof

Also Published As

Publication number Publication date
ZA882080B (en) 1989-04-26
DE3851769D1 (de) 1994-11-17
IL85855A0 (en) 1988-09-30
DK165688B (da) 1993-01-04
EP0357641A1 (en) 1990-03-14
WO1988007526A1 (en) 1988-10-06
HU205744B (en) 1992-06-29
ATE112766T1 (de) 1994-10-15
HUT53882A (en) 1990-12-28
DK652688A (da) 1988-11-23
EP0285919A1 (en) 1988-10-12
NO174507B (no) 1994-02-07
MY103357A (en) 1993-06-30
KR930011489B1 (ko) 1993-12-08
AU619744B2 (en) 1992-02-06
FI894566A0 (fi) 1989-09-27
PH27337A (en) 1993-06-08
KR890700577A (ko) 1989-04-25
NO174507C (da) 1994-05-18
DE3851769T2 (de) 1995-03-09
EP0285919B1 (en) 1994-10-12
PT87068B (pt) 1992-07-31
JPH02502723A (ja) 1990-08-30
NZ224038A (en) 1990-10-26
AU1596488A (en) 1988-11-02
PT87068A (pt) 1988-04-01
NO885096D0 (no) 1988-11-15
CA1321195C (en) 1993-08-10
DK165688C (da) 1993-05-24
IL85855A (en) 1993-02-21
JPH0662574B2 (ja) 1994-08-17
DK652688D0 (da) 1988-11-23
NO885096L (no) 1988-11-15

Similar Documents

Publication Publication Date Title
FI894566A0 (fi) Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar.
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
DE69332577D1 (de) Verfahren zur Herstellung von 13-Ether-Derivaten von Milbemycinen und Zwischenprodukte
HUT62296A (en) Herbicidal composition comprising hydantoin derivative as active ingredient and process for producing the active ingredient
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
AU1832988A (en) Thiazole derivatives
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
EP1147772A4 (en) DRUG COMPOSITIONS FOR THE TREATMENT OF EAR FIBRILLATION
GB2207917B (en) Insecticidal tetrafluorobenzyl esters characterised by enhanced knockdown effect
DE69005984D1 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
HUT54277A (en) Fungicidal compositions comprising 3-(methoxyimino)-propionic acid esters as active ingredient and process for producing the active ingredients
FR2377382A1 (fr) Nouveaux phenylazacycloalcanes utiles comme medicaments
DE69309461D1 (de) Zusammensetzung zur Beschleunigung der Wundheilung
DE69107561D1 (de) Verfahren zur Herstellung von 4-Methylsulfonylbenzoesäurederivate und Zwischenprodukte.
PL264320A1 (en) A fungicide and a method of active matter production
GR3026397T3 (en) Para-hydroxyaniline derivatives, process for their preparation and their use as fungicides or pesticides.
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
ATE30911T1 (de) Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
ES8400751A1 (es) "procedimiento para preparar nuevos derivados organofosfonados".
MY103596A (en) Insecticidal compounds - characterised by enhanced knockdown effect.
ATE74604T1 (de) Substituierte pyrimidochinoxaline.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: SCHERING CORPORATION